MedPath

TARO-OXALIPLATIN

TARO-OXALIPLATIN

Discontinued
DIN Number

02449692

Drug Class

Human

Market Date

Feb 15, 2017

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02449692
AIG Number0152220003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XA03 OXALIPLATIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

OXALIPLATINActive
Strength: 5 MG / ML
Monograph: OXALIPLATIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.